Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan · Delayed Price · Currency is TWD 39.20
-0.25 (-0.63%)
May 8, 2026, 1:58 PM CST
TPEX:7427 Revenue
In the year 2025, Great Novel Therapeutics Biotech & Medicals had annual revenue of 1.21M TWD, down -28.49%. Great Novel Therapeutics Biotech & Medicals had revenue of 623.00K in the half year ending June 30, 2025, a decrease of -86.92%.
Revenue
1.21M
Revenue Growth
-28.49%
P/S Ratio
1,393.70
Revenue / Employee
80.33K
Employees
15
Market Cap
1.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.21M | -480.00K | -28.49% |
| Dec 31, 2024 | 1.69M | -3.17M | -65.26% |
| Dec 31, 2023 | 4.85M | 4.31M | 798.15% |
| Dec 31, 2022 | 540.00K | -90.00K | -14.29% |
| Dec 31, 2021 | 630.00K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Synbio Tech | 1.04B |
| Genomics BioSci & Tech. | 708.38M |
| GenMont Biotech Incorporation | 401.23M |
| Sunny Pharmtech | 253.01M |
| NeoCore Technology | 244.66M |
| Gwo Xi Stem Cell Applied Technology Co. , | 187.02M |
| TaiRx | 27.88M |
| Anti-Microbial Savior BioteQ | 612.00K |